Related Experiment Video
Updated: Sep 15, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
Published on: July 14, 2023
Hypophosphataemia in adults: approach to diagnosis and management
Kajanan Parameshwaran1,2, Mawson Wang1,2, Kirtan Ganda1,2
1Department of Endocrinology and Metabolism, Concord Repatriation General Hospital, Sydney, New South Wales, Australia.
Abstract:
Hypophosphataemia is a common electrolyte disorder which can have clinically significant consequences for bone, muscle, neurological and haematological function. Its causes range from transient transcellular shifts in hospitalised patients to chronic renal phosphate-wasting disorders mediated by fibroblast growth factor 23 (FGF23). A stepwise diagnostic approach enables identification of the underlying aetiology and guides management. While most cases are managed with removal of causative factors and phosphate supplementation, burosumab has revolutionised the treatment of patients with chronic FGF23-mediated hypophosphataemia. This review provides a practical framework for the evaluation and management of hypophosphataemia in adults, with focussed discussion of iron infusion-associated hypophosphataemia, X-linked hypophosphataemia and tumour-induced osteomalacia.
Related Concept Videos
Peritoneal Dialysis III: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Diabetes: Symptoms, Diagnosis, and Complications
Hypoglycemia and Glucagon
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Acute Pancreatitis II: Clinical Manifestations and Management
